PMES 2022 Testimonials: What They Said
- Get straight to the heart of a regional PM market expected to grow with a CAGR of 7.37% annually reaching $8.6 billion by 2032.
- Gain penetrating insights into how biomarkers, targeted therapies, patient health data integration and scientific advances will transform human health.
- Discover the latest advances in personalised solutions across genomics & targeted cancer therapies, regenerative medicine, diagnostics, and treatments.
2
Co-located Events
2
World-Class Conferences
1
Dedicated Exhibition
5,500+
Targeted Visitors
150+
International Speakers
The future of medicine is personal, and it’s precise! Join us at PrecisionMed Exhibition & Summit 2023 – the Middle East’s only dedicated exhibition and summit for precision medicine – and meet the healthcare providers, academic scientists and industry experts who are driving the personalised medicine era.
Discover how precision medicine is taking healthcare from “one size fits all” to a targeted approach.
Exhibition
Discover latest solutions across all areas of precision medicine from 40+ participating countries, including the UK, USA, Germany, and more!
Summit
Learn from 150+ thought leaders and industry experts who will dive deep into the new frontiers of precision medicine technologies, trends, digitisation and more.
Networking & Side Events
Make connections with influential professionals and practitioners in precision medicine to enhance your career, skills, and genome knowledge.
At our co-located event, witness history in the making as aspiring health-tech startups deliver their pitches to source funding from ready investors.
leading speakers from the 2022 edition
Professor Dame Sue Hill
Chief Scientific Officer, England
Exclusive Pre-recorded Session
Min S. Park, PhD
CSO, Sanimed International, Abu Dhabi
Robert C. Green, MD, MPH
Professor of Medicine, Harvard Medical School, Geneticist, Mass General Brigham, Broad Institute; Director, Genomes2People Research Program
Ahmad Abou Tayoun, PhD, FACMG
Director, Genomics Center at Al Jalila Children’s; Associate
Professor of Genetics, Mohammed Bin Rashid University of Medicine and Health Sciences
Heidi Rehm, PhD
Chief Genomics Officer, Department of Medicine, MGH; Co-Director, Medical and Population Genetics, Broad Institute
Exclusive Pre-recorded Session
Hinda Daggag, PhD
Corporate Head of Genetic Projects, SEHA
Khalid Fakhro, PhD
Chief Research Officer,
Sidra Medicine
Richard O Kennedy,
B.Sc., Ph.D., C. Biol., FRSB., F.I.Biol.I., Dip. F.S., Dip. C.S., Dip. Computing, MRIA
Vice-President for Research, Hamad Bin Khalifa University; and Vice-President for Research, Development and Innovation (RDI), Qatar Foundation
Aaron Han, MD, PhD
Consultant, Pathology, COVID Lab, Infection Control, King’s College Hospital London – UAE
Dr. Ihsan Almarzooqi
Co-Founder & Managing Director, Glucare
2023 EXHIBITORS
2023 GOLD sponsor
2023 silver sponsor
The estimated precision medicine market valuation by the year 2025 is about USD 126 billion. The compound annual growth rate of the market is predicted to be 12.48% during the forecast period (2017-2025).
*Source: Market Research Future
Why attend PrecisionMed Summit
- Increase your understanding of the basis for current effective targeted therapies in disease based on molecular, environmental, and patient lifestyle factors.
- Learn more about the methods used to analyse patient diagnostic and molecular data, including the concepts of deep dive data extraction and management, molecular profiling of individual diseases, and digitisation of healthcare delivery.
- Identify global and regional unmet needs in healthcare with the capacity to reduce the burden of malignancy and chronic diseases.
- Update your understanding of current diagnostic and therapeutic clinical guidelines and best practices in precision medicine in all areas.
- Network with global key opinion leaders, scientists, healthcare professionals, policymakers, and managers.
- Explore new products, technologies & services, exhibited by global experts and suppliers with expertise in the development and application of molecular diagnostics, tele-health, and eHealth tools that guide individualised or personalised patient diagnosis and treatment.
- Earn CME/CPD accreditation points.
